Marc Rubin is Director at GALECTIN THERAPEUTICS INC (GALT). They have made 15 open-market trades across 5 companies since 2010, most recently 2026-03-20.
CIK 0001412377
11 open-market purchases totalling $405K since 2010, against 4 sales. Across 7 scored buys the stock is up 23.0% at ninety days, and 23.9 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 57% | 43% |
| Avg Move | -12.9% | +25.9% | +23.0% |
| Alpha | -10.3% | +26.4% | +23.9% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GALT | SELL | 2019-02-21 | 2019-02-25 | $6.02 | $574K | -11.6% | -16.7% | -26.3% |
| GALT | SELL | 2019-02-21 | 2019-02-25 | $6.02 | $261K | -11.6% | -16.7% | -26.3% |
| CRIS | SELL · 10b5-1 | 2019-01-23 | 2019-01-25 | $1.05 | $19K | -7.2% | -11.2% | +42.4% |
| TTNP | BUY | 2018-09-21 | 2018-09-25 | $0.25 | $100K | -2.2% | +81.0% | +0.0% |
| GALT | SELL | 2018-09-04 | 2018-09-06 | $6.58 | $78K | +8.1% | -7.4% | -9.2% |
| GALT | SELL | 2018-08-30 | 2018-09-04 | $6.08 | $353K | -16.6% | -17.4% | -22.5% |
| GALT | BUY | 2017-12-08 | 2017-12-08 | $1.85 | $13K | -3.3% | +107.8% | +125.9% |
| CRIS | BUY | 2017-11-16 | 2017-11-16 | $0.98 | $25K | -14.3% | -17.0% | -42.8% |
| TTNP | BUY | 2016-01-11 | 2016-01-11 | $3.25 | $16K | +3.7% | +13.3% | +82.0% |
| TTNP | BUY | 2015-08-28 | 2015-08-31 | $0.72 | $36K | -20.9% | -1.6% | -1.6% |
| TTNP.OB | BUY | 2014-10-09 | 2014-10-14 | $0.48 | $48K | N/A | N/A | N/A |
| GALT | BUY | 2013-12-04 | 2013-12-04 | $8.69 | $26K | -20.0% | +1.3% | +1.3% |
| TTNP.OB | BUY | 2013-06-17 | 2013-06-19 | $0.45 | $23K | N/A | N/A | N/A |
| TTNP.OB | BUY | 2011-11-18 | 2011-11-21 | $1.27 | $49K | N/A | N/A | N/A |
| GALT.OB | BUY | 2011-10-18 | 2011-10-20 | $0.96 | $19K | N/A | N/A | N/A |
| CRIS | BUY | 2010-12-10 | 2010-12-14 | $1.89 | $50K | -33.2% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.